MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunome (IMNM) Ownership - Who owns Immunome?
Immunome Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
763.97M
P/E Ratio
N/A
Total Cash
317.32M
Projected Growth
N/A
Total Debt
4.77M
Revenue
10.94M
Risk (Beta)
2.89
Dividend Yield
N/A
Total Cash/Share
3.65
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price
Fundamentals
IMNM
Capitalization
764M
P/E Ratio
N/A
Risk (Beta)
2.89
Dividend Yield
N/A
Total Cash
317M
Total Cash/Share
3.65
Total Debt
4.77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.17%
Revenue
10.9M
ROE
N/A
Book Value
307M
P/B Ratio
2.48
Cash Flow
N/A
Earnings
-3.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
10.49
Current Revenue Per Employee
22335.88
Dividends Per Share - Security
N/A
EBITDA
-175.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-61.93
Shares Held By Institutions
735M
Shares Outstanding - Current
87M
Total Liabilities
35.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.420
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com